Robert W. Hesslein is CLO & VP at Foundation Medicine, Inc. (FMI). They have made 14 open-market trades across 1 company since 2014, most recently 2025-03-03.
CIK 0001585018
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYGR | SELL · 10b5-1 | 2023-03-20 | 2023-03-22 | $7.76 | $34K | +8.1% | +6.1% | +86.3% |
| VYGR | SELL · 10b5-1 | 2023-02-17 | 2023-02-22 | $7.45 | $25K | +11.2% | +2.9% | +72.8% |
| VYGR | SELL · 10b5-1 | 2023-02-13 | 2023-02-15 | $7.67 | $22K | -3.8% | +6.2% | +52.3% |
| VYGR | SELL · 10b5-1 | 2023-01-17 | 2023-01-19 | $9.85 | $22K | -1.0% | -25.3% | -17.1% |
| VYGR | SELL · 10b5-1 | 2022-04-04 | 2022-04-06 | $8.25 | $23K | +7.0% | -30.4% | -28.0% |
| VYGR | SELL · 10b5-1 | 2022-03-21 | 2022-03-23 | $8.29 | $41K | -5.0% | -18.0% | -41.9% |
| VYGR | SELL · 10b5-1 | 2022-02-17 | 2022-02-22 | $3.55 | $15K | +5.7% | +169.4% | +75.1% |
| VYGR | SELL · 10b5-1 | 2022-02-11 | 2022-02-15 | $3.36 | $11K | +8.2% | +92.9% | +77.9% |
| VYGR | SELL · 10b5-1 | 2021-04-05 | 2021-04-07 | $4.95 | $16K | -6.5% | -9.8% | -18.6% |
| VYGR | SELL · 10b5-1 | 2021-02-11 | 2021-02-16 | $7.55 | $24K | -21.9% | -28.5% | -37.5% |
| VYGR | SELL · 10b5-1 | 2020-04-03 | 2020-04-07 | $8.51 | $26K | +8.9% | +12.8% | +35.7% |
| FMI | SELL | 2018-07-02 | 2018-07-05 | $136.66 | $689K | +0.1% | N/A | N/A |
| FMI | SELL | 2018-04-02 | 2018-04-03 | $74.88 | $237K | +16.3% | +1.5% | +98.4% |
| FMI | SELL | 2018-01-16 | 2018-01-18 | $64.30 | $2.3M | +8.5% | +15.6% | +12.5% |
| FMI | SELL | 2018-01-02 | 2018-01-03 | $64.00 | $119K | +1.9% | +7.3% | +10.7% |
| FMI | SELL | 2017-10-02 | 2017-10-04 | $38.80 | $142K | +8.0% | +27.1% | +52.3% |
| FMI | SELL | 2017-07-06 | 2017-07-07 | $38.84 | $328K | -1.0% | +0.0% | +16.3% |
| FMI | SELL | 2017-05-12 | 2017-05-16 | $33.87 | $34K | +6.7% | +9.8% | +10.9% |
| FMI | SELL | 2017-04-03 | 2017-04-05 | $31.96 | $39K | +6.1% | +16.7% | +29.4% |
| FMI | SELL | 2017-03-16 | 2017-03-20 | $31.67 | $395K | -1.1% | -2.0% | +21.4% |
| FMI | SELL | 2017-01-03 | 2017-01-05 | $17.60 | $140K | -0.5% | +6.6% | +67.5% |
| FMI | SELL | 2016-10-04 | 2016-10-05 | $23.65 | $29K | -7.4% | -19.4% | -25.1% |
| FMI | SELL | 2016-07-01 | 2016-07-06 | $17.53 | $143K | +10.9% | +15.4% | +11.7% |
| FMI | SELL | 2015-03-05 | 2015-03-10 | $47.24 | $219K | -21.9% | -5.6% | -5.6% |
| FMI | SELL | 2015-03-02 | 2015-03-04 | $48.35 | $69K | -21.9% | -5.6% | -5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.